Results 11 to 20 of about 3,364,352 (377)

The influence of internal pressure and neuromuscular agents onC. elegansbiomechanics: an empirical and multi-compartmentalin silicomodelling study

bioRxiv, 2023
The function of a specific tissue and its biomechanics are interdepended, with pathologies or ageing often being intertwined with structural decline. The biomechanics of Caenorhabditis elegans (C. elegans), a model organism widely used in pharmacological
Essmann CL, Elmi M, Rekatsinas C, Chrysochoidis N, Shaw M, Pawar V, Srinivasan MA, Vavourakis V.   +7 more
europepmc   +2 more sources

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review

BMC Anesthesiology, 2018
Background Neuromuscular blocking drugs (NMBD) are administered intra-operatively to facilitate intubation and to achieve muscle relaxation for surgical procedures.
Khawaja Rashid Hafeez, Arvind Tuteja, Mandeep Singh, David T. Wong, Mahesh Nagappa, Frances Chung, Jean Wong   +6 more
doaj   +2 more sources

Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study [PDF]

British medical journal, 2012
Objective: To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design: Prospective, propensity score matched cohort study.
Bateman, Brian Thomas, Ehrenfeld, Jesse M., Eikermann, Matthias, Grosse-Sundrup, Martina, Henneman, Justin P, Kurth, Tobias, Martinez, Elizabeth, Nguyen, Nicole Thuy, Sandberg, Warren S, Uribe, Jose Villa   +9 more
core   +2 more sources

Neuromuscular Weakness and Paralysis Produced by Snakebite Envenoming: Mechanisms and Proposed Standards for Clinical Assessment

Toxins, 2023
Respiratory and airway-protective muscle weakness caused by the blockade of neuromuscular transmission is a major cause of early mortality from snakebite envenoming (SBE).
Philip E. Bickler, Michael Abouyannis, Ashish Bhalla, Matthew R. Lewin   +3 more
doaj   +2 more sources

Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients [PDF]

Medicina
Background and Objectives: Neuromuscular blocking agents are essential to ensure optimal surgical conditions during general anesthesia. Sugammadex, a selective binding agent, is widely used to reverse neuromuscular blockade.
Ji-Yoon Jung, Sung-Ae Cho, Woojin Kwon, Hongwook Kim, Tae-Yun Sung   +4 more
doaj   +2 more sources

Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials [PDF]

Critical Care, 2013
IntroductionRandomized trials investigating neuromuscular blocking agents in adult acute respiratory distress syndrome (ARDS) have been inconclusive about effects on mortality, which is very high in this population.
Waleed Alhazzani, Mohammed Alshahrani, Roman Jaeschke, Jean Marie Forel, Laurent Papazian, Jonathan Sevransky, Maureen O. Meade   +6 more
openalex   +2 more sources

Myotonia and Neuromuscular Blocking Agents [PDF]

Anesthesiology, 1978
Mark M. Mitchell, John J. Savarese, Hassan H. Ali   +2 more
openaire   +5 more sources

"Thrombolysis" by a neuromuscular blocking agent [PDF]

Clinical Research in Cardiology, 2006
Pascale, Patrizio, Quartenoud, B
openaire   +6 more sources

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents [PDF]

JA Clinical Reports, 2019
Michiko Higashi, Takahiro Tamura, Yushi U. Adachi   +2 more
doaj   +4 more sources

The Potentiation of Neuromuscular Blocking Agents by Quinidine [PDF]

Anesthesiology, 1967
Ronald D. Miller, B. G. Katzung, Walter L. Way   +2 more
openaire   +4 more sources